Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial Revascularization.

Med Arch · 2019 · PMC6445624 · PMID 31097854

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

By comparing the incidence in the treated groups, we established a marginally significant Pearson-time rate for the POAF between the second and third groups of BB+Amiodarone and BB+Rosuvastatin, and this difference remained significant when we compared the incidence between the BB+Amiodarone treated group and the other two groups together.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.